Haleon plc (NYSE:HLN) Given Consensus Rating of “Buy” by Brokerages

Haleon plc (NYSE:HLN) has been assigned a consensus rating of “Buy” from the six brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $10.95.

HLN has been the subject of several recent research reports. The Goldman Sachs Group cut Haleon from a “buy” rating to a “neutral” rating in a research note on Tuesday, August 6th. Berenberg Bank assumed coverage on shares of Haleon in a report on Tuesday, August 6th. They set a “buy” rating for the company. Morgan Stanley raised their price objective on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a report on Friday, September 20th. Finally, UBS Group upgraded Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st.

Institutional Investors Weigh In On Haleon

Hedge funds and other institutional investors have recently modified their holdings of the stock. Fortitude Family Office LLC purchased a new stake in Haleon in the 3rd quarter valued at approximately $28,000. Toronto Dominion Bank grew its holdings in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares in the last quarter. Cultivar Capital Inc. purchased a new position in shares of Haleon during the second quarter valued at approximately $40,000. Hexagon Capital Partners LLC grew its stake in Haleon by 66.6% in the 2nd quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company’s stock worth $55,000 after acquiring an additional 2,677 shares during the period. Finally, Prospera Private Wealth LLC acquired a new position in Haleon in the 3rd quarter valued at $57,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Trading Up 0.8 %

NYSE:HLN opened at $9.56 on Friday. Haleon has a 12-month low of $7.89 and a 12-month high of $10.80. The firm has a market cap of $43.25 billion, a PE ratio of 28.10, a price-to-earnings-growth ratio of 2.86 and a beta of 0.30. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock has a fifty day moving average price of $10.03 and a 200 day moving average price of $9.37.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.